The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Want to have a baby but not treatment

Nov 23, 2004

I have been HIV+ for the past 10 years, I now want to have a baby but do not want to go on treatment but very desperate to have a baby. My partner is negative we can go for artificial insermination, how high is the risk to pass the virus to the baby if we use niverapine? my cd4 count stands at 430

Response from Dr. Pierone

The risk of mother to infant transmission of HIV on no medications is about 25 percent. With the use of nevirapine alone it is reduced to about 8 percent. With use of traditional triple agent HAART it is less than one percent. These numbers speak for themselves.

The outcomes in children born to mothers on HAART are excellent and only rare cases of toxicity due to HAART have been reported. If one does the risk benefit calculus the arguments in favor of standard HAART are compelling. Thanks for posting and best of luck.

Newly diagnosed with hep c,also have hiv..........

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint